Surgical Aortic Valve Replacement For Bicuspid And Tricuspid Valve Disease: 7-Year Outcomes In >1100 Patients
SAVR with the Avalus bioprosthesis yielded excellent 7-year outcomes for patients with either a congenital bicuspid or tricuspid valve. Hemodynamic performance and reintervention rates were similar between cohorts with low rates of other valve-related adverse events.
Authors
- G. Michael Deeb (ORCID: https://orcid.org/0000-0002-4698-2789)
- Michael G. Moront
- Marc Ruel (ORCID: https://orcid.org/0000-0002-0487-1319)
- Joseph F. Sabik (ORCID: https://orcid.org/0000-0002-1186-343X)
- Ralf Günzinger
- Robert J.M. Klautz (ORCID: https://orcid.org/0000-0002-6507-3855)
- Michael J. Reardon (ORCID: https://orcid.org/0000-0002-2880-6132)
- Louis Labrousse (ORCID: https://orcid.org/0000-0001-8542-9049)
- François Dagenais
- Tianhua Wu
Institutions
- Houston Methodist (US)
- University of Ottawa (CA)
- University of Michigan (US)
- University Hospitals of Cleveland (US)
- Leiden University Medical Center (NL)
- Montreal Heart Institute (CA)
- ProMedica Toledo Hospital (US)
- Deutsches Herzzentrum München (DE)
- University School (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- PubMed
- Published
- 2024-11-21
- DOI
- https://doi.org/10.48729/pjctvs.531
- Citations
- 1
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.40